HUMACYTE INC (HUMA:NASDAQ)
$0.6937 -0.0066 (-0.9425%)
Analysed HUMACYTE INC (HUMA:NASDAQ) News Sources
HUMA Stock Plunges After-Hours On Proposed Share Offering Even As Dialysis Data Impresses
10-06-2026
stocktwits.com
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
11-06-2026
yahoo.com
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
11-06-2026
yahoo.com
Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting
15-06-2026
yahoo.com
Humacyte, Inc. (HUMA) Upgraded to Buy: Here's What You Should Know
15-06-2026
yahoo.com
Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know
16-06-2026
yahoo.com
Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet
19-06-2026
yahoo.com
Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market
25-06-2026
yahoo.com
Humacyte (HUMA) Stock Fair Value Falls As Split Analyst Views Follow V012 Data
27-06-2026
yahoo.com
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why
30-06-2026
yahoo.com
What is the current price of HUMACYTE INC (HUMA:NASDAQ)?
The current price of HUMACYTE INC (HUMA:NASDAQ) is $0.6937.
HUMACYTE INC (HUMA:NASDAQ) absolute price change since previous trading day?
The absolute price change of HUMACYTE INC (HUMA:NASDAQ) since the previous trading day is $-0.0066.
HUMACYTE INC (HUMA:NASDAQ) percentage price change since previous trading day?
The percentage price change of HUMACYTE INC (HUMA:NASDAQ) since the previous trading day is -0.9425%.
What is the most recent average sentiment score for HUMACYTE INC (HUMA:NASDAQ)?
The most recent average sentiment score for HUMACYTE INC (HUMA:NASDAQ) is 50 out of 100.
What is the most recent average sentiment for HUMACYTE INC (HUMA:NASDAQ)?
The most recent sentiment for HUMACYTE INC (HUMA:NASDAQ) is .
SEC-8K** Filing Available For HUMACYTE INC (HUMA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.